Cargando…

User-Friendly and Parallelized Generation of Human Induced Pluripotent Stem Cell-Derived Microtissues in a Centrifugal Heart-on-a-Chip

The persistence of cardiovascular diseases as leading global causes of death has spurred attempts to develop microphysiological systems integrating engineered cardiac tissue. These novel platforms enable investigation of mechanisms underlying myocardial pathology as well as in vitro screening of can...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Oliver, Zeifang, Lisa, Fuchs, Stefanie, Sailer, Carla, Loskill, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535963/
https://www.ncbi.nlm.nih.gov/pubmed/30968738
http://dx.doi.org/10.1089/ten.tea.2019.0002
_version_ 1783421668901781504
author Schneider, Oliver
Zeifang, Lisa
Fuchs, Stefanie
Sailer, Carla
Loskill, Peter
author_facet Schneider, Oliver
Zeifang, Lisa
Fuchs, Stefanie
Sailer, Carla
Loskill, Peter
author_sort Schneider, Oliver
collection PubMed
description The persistence of cardiovascular diseases as leading global causes of death has spurred attempts to develop microphysiological systems integrating engineered cardiac tissue. These novel platforms enable investigation of mechanisms underlying myocardial pathology as well as in vitro screening of candidate drugs for possible cardiotoxicity. However, most of the developed systems rely on manual cell injection protocols, resulting in nonstandardized tissue creation and requiring excessive amounts of cells. To address these issues, we present a novel integrated device enabling the parallelized generation of cardiac microtissues based on human induced pluripotent stem cells as well as rat primary cardiomyocytes in an especially designed multichamber system that provides a precisely controlled physiological environment. The next-generation device utilizes a centrifugally assisted cell loading procedure, which enables robust generation of tissues devoid of air bubbles. It requires solely a minimal amount of cells to create uniaxially aligned cardiac muscle fibers, displaying well-aligned collections of sarcomeres. The viability and functionality of myocardial tissues can be maintained for long time periods, while detailed spatial and temporal beating kinetics can be examined by optical means. As proof of concept, the applicability of the system for drug testing was demonstrated, highlighting the potential of this user-friendly and economical centrifugal heart-on-a-chip for future applications in pharmaceutical industry and mechanistic research. IMPACT STATEMENT: With the ultimate goal in tissue engineering of approaching in vivo functionality as closely as possible, organ-on-a-chip (OoC) systems provide unprecedented game-changing opportunities by enabling creation of perfused three-dimensional tissues. Most of the recently developed OoC systems, however, require complex handling steps. Hence, a large gap still exists between technology development and collection of valuable biological data in a standardized medium- or high-throughput manner. The system presented here bridges this gap by providing a user-friendly framework for the parallelized creation of multiple physiologically relevant tissues, which could be applicable in every laboratory without additional equipment.
format Online
Article
Text
id pubmed-6535963
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-65359632019-05-28 User-Friendly and Parallelized Generation of Human Induced Pluripotent Stem Cell-Derived Microtissues in a Centrifugal Heart-on-a-Chip Schneider, Oliver Zeifang, Lisa Fuchs, Stefanie Sailer, Carla Loskill, Peter Tissue Eng Part A Special Issue Articles The persistence of cardiovascular diseases as leading global causes of death has spurred attempts to develop microphysiological systems integrating engineered cardiac tissue. These novel platforms enable investigation of mechanisms underlying myocardial pathology as well as in vitro screening of candidate drugs for possible cardiotoxicity. However, most of the developed systems rely on manual cell injection protocols, resulting in nonstandardized tissue creation and requiring excessive amounts of cells. To address these issues, we present a novel integrated device enabling the parallelized generation of cardiac microtissues based on human induced pluripotent stem cells as well as rat primary cardiomyocytes in an especially designed multichamber system that provides a precisely controlled physiological environment. The next-generation device utilizes a centrifugally assisted cell loading procedure, which enables robust generation of tissues devoid of air bubbles. It requires solely a minimal amount of cells to create uniaxially aligned cardiac muscle fibers, displaying well-aligned collections of sarcomeres. The viability and functionality of myocardial tissues can be maintained for long time periods, while detailed spatial and temporal beating kinetics can be examined by optical means. As proof of concept, the applicability of the system for drug testing was demonstrated, highlighting the potential of this user-friendly and economical centrifugal heart-on-a-chip for future applications in pharmaceutical industry and mechanistic research. IMPACT STATEMENT: With the ultimate goal in tissue engineering of approaching in vivo functionality as closely as possible, organ-on-a-chip (OoC) systems provide unprecedented game-changing opportunities by enabling creation of perfused three-dimensional tissues. Most of the recently developed OoC systems, however, require complex handling steps. Hence, a large gap still exists between technology development and collection of valuable biological data in a standardized medium- or high-throughput manner. The system presented here bridges this gap by providing a user-friendly framework for the parallelized creation of multiple physiologically relevant tissues, which could be applicable in every laboratory without additional equipment. Mary Ann Liebert, Inc., publishers 2019-05-01 2019-05-10 /pmc/articles/PMC6535963/ /pubmed/30968738 http://dx.doi.org/10.1089/ten.tea.2019.0002 Text en © Oliver Schneider et al. 2019; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Special Issue Articles
Schneider, Oliver
Zeifang, Lisa
Fuchs, Stefanie
Sailer, Carla
Loskill, Peter
User-Friendly and Parallelized Generation of Human Induced Pluripotent Stem Cell-Derived Microtissues in a Centrifugal Heart-on-a-Chip
title User-Friendly and Parallelized Generation of Human Induced Pluripotent Stem Cell-Derived Microtissues in a Centrifugal Heart-on-a-Chip
title_full User-Friendly and Parallelized Generation of Human Induced Pluripotent Stem Cell-Derived Microtissues in a Centrifugal Heart-on-a-Chip
title_fullStr User-Friendly and Parallelized Generation of Human Induced Pluripotent Stem Cell-Derived Microtissues in a Centrifugal Heart-on-a-Chip
title_full_unstemmed User-Friendly and Parallelized Generation of Human Induced Pluripotent Stem Cell-Derived Microtissues in a Centrifugal Heart-on-a-Chip
title_short User-Friendly and Parallelized Generation of Human Induced Pluripotent Stem Cell-Derived Microtissues in a Centrifugal Heart-on-a-Chip
title_sort user-friendly and parallelized generation of human induced pluripotent stem cell-derived microtissues in a centrifugal heart-on-a-chip
topic Special Issue Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535963/
https://www.ncbi.nlm.nih.gov/pubmed/30968738
http://dx.doi.org/10.1089/ten.tea.2019.0002
work_keys_str_mv AT schneideroliver userfriendlyandparallelizedgenerationofhumaninducedpluripotentstemcellderivedmicrotissuesinacentrifugalheartonachip
AT zeifanglisa userfriendlyandparallelizedgenerationofhumaninducedpluripotentstemcellderivedmicrotissuesinacentrifugalheartonachip
AT fuchsstefanie userfriendlyandparallelizedgenerationofhumaninducedpluripotentstemcellderivedmicrotissuesinacentrifugalheartonachip
AT sailercarla userfriendlyandparallelizedgenerationofhumaninducedpluripotentstemcellderivedmicrotissuesinacentrifugalheartonachip
AT loskillpeter userfriendlyandparallelizedgenerationofhumaninducedpluripotentstemcellderivedmicrotissuesinacentrifugalheartonachip